Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, October 3, 2017

Public edition | newswise.com

Newswise Cancer Research Wire for 03-Oct-2017
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



Rare Benign Tumors Hold the “Genetic Recipe” to Combat Diabetes

Mount Sinai researchers discover that insulinomas contain novel molecular pathways and reveal the map to regenerate insulin-producing cells

– Mount Sinai Health System

Nature Medicine

Embargo expired on 03-Oct-2017 at 05:00 ET


By Decoding How HPV Causes Cancer, Researchers Find a New Potential Treatment Strategy

A study that teases apart the biological mechanisms by which human papillomaviruses (HPV) cause cancer has found what researchers at Georgetown University Medical Center say is a new strategy that might provide targeted treatment for these cancers. ...

– Georgetown University Medical Center

Oncotarget; NIH R33CA177466, NIH R21CA180524, NIH P30 CA051008, Center for Cell Reprogramming

Embargo expired on 02-Oct-2017 at 00:05 ET


Doctors Define "Safe and Effective" Margins For "One and Done" Skin Removal Around Suspicious Moles

By carefully tracing a line of at least 2 millimeters outside of and around the edges of a mole that is suspected of being a cancer, doctors can remove all of its cells and avert the need for a second surgery.

– NYU Langone Health

Journal of the American Academy of Dermatology

Embargo expired on 02-Oct-2017 at 03:00 ET


DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer

In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.

– University of California San Diego Health

Clinical Cancer Research

Embargo expired on 02-Oct-2017 at 00:05 ET


New Insight on Nuclear Organization of DNA and its Impact on Patterns of Mutations in Cancer

Research by Rutgers Cancer Institute of New Jersey investigators and others shows that the architecture of a cell’s nucleus influences the type and frequency of mutations in cancer genomes beyond the effects already captured by DNA packaging and or...

– Rutgers Cancer Institute of New Jersey

Nature Structural & Molecular Biology, Oct-2017

Embargo expired on 02-Oct-2017 at 11:00 ET


Genetic Test Successfully Detects Some Asymptomatic Pancreatic Cancers

PancreaSeq® analyzed mutations known to be associated with precursors to pancreatic cancers.

– Health Sciences at the University of Pittsburgh

Gut - Journal of the British Society of Gastroenterology


Five Things Everyone Should Know About Breast Cancer

With October marking National Breast Cancer Awareness month, a breast cancer expert at Yale Cancer Center, sorts out the facts about breast cancer and offers simple ways to reduce risk.

– Yale Cancer Center


5 Things You Need to Know About Cervical Cancer

There are several types of gynecologic cancers that affect the female reproductive system, including endometrial, ovarian, cervical, vaginal and vulvar cancer.

– City of Hope


Breast Cancer Experts Available From IU School of Medicine to Speak with Media

In preparation for Breast Cancer Awareness month, five expert IU faculty surgeons and researchers are available to discuss breast cancer, breast disease, current research initiatives, and best surgical practice and treatment for breast cancer patient...

Expert Available

– Indiana University


Protein Power, Latino Youth Health, New Triage Tool, and More in the Public Health News Source

The latest research, experts and features in Public Health in the Public Health News Source

– Newswise


Promising Drug Combination Silences the Rage of Graft-Versus-Host Disease

To pass the nearly 180 days she was a patient in Seattle Children’s Cancer Unit with graft-versus-host disease (GVHD), London Bowater took orders from her doctors, nurses and other patients and families for friendship bracelets that she would braid...

– Seattle Children's Hospital

Science Translational Medicine


m6A Enzymes Found to Be Central to the Development of AML

A team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and Weill-Cornell Medical College have identified, for the first time, a new molecular pathway that is required for acute myeloid leukemia (AML) development. This work could prov...

– Memorial Sloan Kettering Cancer Center

Nature Medicine


The Oncogene FOXQ1 Promotes Some Tumor Types, Suppresses Another

In a new study published in Cell Reports, scientists report an unexpected finding — that the oncogene FOXQ1 suppresses the growth of melanoma cells.

– Roswell Park Cancer Institute

Cell Reports; Cell Reports; P30CA16056; R01CA190533


Awareness of Cognitive Impairments from Breast Cancer Treatment

...

– Rutgers Cancer Institute of New Jersey


Penn Medicine Develops Model to Predict ER Visits in Lung Cancer Patients

A pilot program that uses big data to predict which lung cancer patients will require a trip to an emergency department (ED) successfully anticipated a third of all ED visits over a two week trial period, and was further able to identify which patien...

– Perelman School of Medicine at the University of Pennsylvania

American Society of Therapeutic Radiation Oncology (ASTRO) 2017 Annual Meeting


Editing Genes One by One Throughout Colorectal Cancer Cell Genome Uncovers New Drug Targets

Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors. Instead of targeting mutant KRAS itself, researchers at Uni...

– University of California San Diego Health

Cancer Research


Study Finds “Standard Care” Treatments in Breast Cancer Clinical Trials Not Always Standard

As reported in JNCCN, a recent study by researchers at The University of Sydney found that 29% of breast cancer clinical trials lack control arms consistent with the standard of care.

– National Comprehensive Cancer Network® (NCCN®)

JNCCN – Journal of the National Comprehensive Cancer Network


Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment

A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized non-small cell lung cancer (NSCLC) and afford physicians additional lead time to personalize treatment for recurrent disease.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017


Accelerated Breast Radiation Therapy Following Mastectomy Shortens Treatment Time While Maintaining Tumor Control

Radiation therapy following mastectomy for intermediate-stage, high-risk breast cancer can be shortened from five to three weeks while maintaining tumor control rates in the breast and surrounding region that are equivalent to conventional treatment,...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017


Immune Response Prognostic for Prostate Cancer Survival, Recurrence and Response to Radiation Therapy

A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival outcomes. The analysis of more than 9,000 prostate tumors...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017


Teen First in VA. To Receive Cancer Gene Therapy in UVA Clinical Trial

UVA has administered its first dose of an experimental gene therapy for a deadly form of treatment-resistant pediatric leukemia.

– University of Virginia Health System


Breast Cancer Treatment Has Evolved. Here’s Where We Are.

There is no “one size fits all approach” when it comes to treating breast cancer. The disease is made up of several subtypes, and ideally each type should be treated with therapies that target the unique underlying biological problems.

Expert Available

– University of California, Los Angeles (UCLA), Health Sciences


Federal Budget Analyst and Cancer Survivor to Open AACI/CCAF Annual Meeting

The 2017 annual meeting of the Association of American Cancer Institutes (AACI) and the Cancer Center Administrators Forum (CCAF) will feature a keynote talk by Stan Collender, a federal budget issues expert and Merkel cell carcinoma survivor. The me...

– Association of American Cancer Institutes (AACI)


Cancer Treatment: Bringing Patients Onboard

With $1 million in funding from the Canadian Institutes of Health Research, PAROLE-Onco will integrate patient-partners into the health care teams of the oncology departments of six Quebec health institutions. This is the first research project of it...

– Centre hospitalier de l'Université de Montréal (CHUM)


Policy and Public Affairs


Queen’s University Research Highlights Inequality for a Quarter of Cancer Patients

Advances in health care are providing cancer patients with longer lives and a better quality of life. However, a study published in the British Journal of Cancer by researchers at Queen’s University Belfast and The Belfast Trust highlights that 25%...

– Queen's University Belfast

British Journal of Cancer


Briefing: Reducing Medical Costs and Improving Patient Outcomes Through Laboratory Testing

By enabling early disease detection and personalized treatment, laboratory tests can save lives as well as billions in medical costs each year. Join AACC and leading experts in laboratory medicine for a discussion of how clinical tests can be leverag...

– American Association for Clinical Chemistry (AACC)


Announcements


Dr. Roshni Rao Appointed Chief of Breast Surgery at NewYork-Presbyterian/Columbia University Medical Center

Dr. Roshni Rao, a renowned expert in breast care, has been appointed chief of the Breast Surgery Program at NewYork-Presbyterian/Columbia University Medical Center, effective October 3.

– New York-Presbyterian Hospital

Embargo expired on 03-Oct-2017 at 06:00 ET


Shlomo Melmed, MB, ChB, Dean of Cedars-Sinai Medical Faculty, Honored by Endocrine Society

Shlomo Melmed, MB, ChB, executive vice president, Academic Affairs, and dean of the medical faculty at Cedars-Sinai, has won the 2018 Outstanding Scholarly Physician Award from the Endocrine Society, the largest global membership organization represe...

– Cedars-Sinai


Southern Research-Bionetix Collaboration Seeks Novel Cancer Drug That Targets a Genetic Switch

Southern Research and Bionetix Inc., a South Korea-based biotech firm, have signed a research and license agreement to develop a new anti-cancer drug that affects a key genetic switch associated with suppression and regulation of the growth of certai...

– Southern Research


Hackensack Meridian Health Bayshore Medical Center Receives Accreditation from the American College of Surgeons, National Accreditation Program for Breast Centers

Bayshore Medical Center in Holmdel has been granted a three-year, full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. Accreditation by the NAPBC...

– Hackensack Meridian Health


UK Researchers Seek to Identify Ways to Relieve Post-Chemotherapy Cognitive Impairment

Many cancer survivors experience devastating cognitive impairment following chemotherapy. Researchers at UK are trying to identify strategies to relieve these symptoms.

– University of Kentucky


Magee-Womens Research Institute Announces Landmark Award to Advance Scientific Discoveries in Women’s Health

To advance ongoing and innovative research in women’s health, a $1 million prize will be awarded to a team of top scientists at the inaugural Magee 9-90™ Research Summit, taking place Oct. 8-10, 2018, in Pittsburgh. The international summit will ...

– Magee-Womens Research Institute


UTHealth Researchers Receive $2.5 Million to Develop Anal Cancer Screening Protocol

The National Institutes of Health has awarded a $2.5 million grant to researchers at The University of Texas Health Science Center at Houston (UTHealth) to develop a standard protocol for anal cancer screenings for men who have sex with men.

– University of Texas Health Science Center at Houston


UTHealth’s Jim Zheng Awarded $5.8 Million CPRIT Grant to Mine Cancer Data for Cures

In keeping with the shift in cancer research from data generation to data analysis, bioinformatician W. Jim Zheng, Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) has been awarded a five-year, $5.8 million Cancer Prevent...

– University of Texas Health Science Center at Houston


Expert Pitch


Fighting Against Triple-Negative Breast Cancer

– Sanford Burnham Prebys Medical Discovery Institute


Researchers Available to Discuss Cancer Vaccine Potential, Diagnostics, Personalized Medicine and More During Breast Cancer Awareness Month

– Arizona State University (ASU)


Physician Cancer Expert Available to Comment on Breast Cancer Prevalence, Diagnosis, Treatment

– College of American Pathologists (CAP) Foundation


Researchers at Northwestern Medicine Want to Get Ahead of the Game When It Comes to Women with a New Diagnosis of DCIS

– Northwestern Medicine

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

  Newswise

 Seattle Children's Hospital

 University of Virginia Health System

 University of California San Diego Health

 University of California, Los Angeles (UCLA), Health Sciences

 Health Sciences at the University of Pittsburgh

 College of American Pathologists (CAP) Foundation

 Northwestern Medicine

 Queen's University Belfast

 University of Kentucky

 University of Texas M. D. Anderson Cancer Center


Subscribe / Unsubscribe
Edit my preferences

© 2017 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us